Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis.
Gutiérrez-García G, Villarreal J, Garrote M, Rovira M, Blasco M, Suárez-Lledó M, Rodríguez-Lobato LG, Charry P, Rosiñol L, Marín P, Pedraza A, Solano MT, Ramos C, de Llobet N, Lozano M, Cid J, Martínez C, Poch E, Carreras E, Urbano-Ispizua Á, Fernández-Avilés F, Pereira A, Quintana LF. Gutiérrez-García G, et al. Among authors: de llobet n. Bone Marrow Transplant. 2020 Jul;55(7):1264-1271. doi: 10.1038/s41409-020-0843-3. Epub 2020 Feb 26. Bone Marrow Transplant. 2020. PMID: 32103146
Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis.
Gutiérrez-García G, Cibeira MT, Rovira M, Fernández de Larrea C, Tovar N, Rodríguez-Lobato LG, Rosiñol L, Marín P, Solano-Vega J, Suárez-Lledó M, Bataller A, Solano MT, de Llobet N, Domenech A, Borràs N, Lozano M, Cid J, Martínez C, Urbano-Ispizua Á, Esteve J, Carreras E, Fernández-Avilés F, Bladé J. Gutiérrez-García G, et al. Among authors: de llobet n. Bone Marrow Transplant. 2019 Aug;54(8):1295-1303. doi: 10.1038/s41409-019-0447-y. Epub 2019 Jan 21. Bone Marrow Transplant. 2019. PMID: 30664727
A reproducible and safe at-home allogeneic haematopoietic cell transplant program: first experience in Central and Southern Europe.
Gutiérrez-García G, Rovira M, Arab N, Gallego C, Sánchez J, Ángeles Álvarez M, Ayora P, Domenech A, Borràs N, Gerardo Rodríguez-Lobato L, Rosiñol L, Marín P, Pedraza A, Martínez-Roca A, Carcelero E, Dolores Herrera M, Teresa Solano M, Ramos C, de Llobet N, Serrahima A, Lozano M, Cid J, Martínez C, Suárez-Lledó M, Urbano-Ispizua Á, Fernández-Avilés F. Gutiérrez-García G, et al. Among authors: de llobet n. Bone Marrow Transplant. 2020 May;55(5):965-973. doi: 10.1038/s41409-019-0768-x. Epub 2020 Jan 13. Bone Marrow Transplant. 2020. PMID: 31932656
PTCY and Tacrolimus for GVHD Prevention for Older Adults Undergoing HLA-Matched Sibling and Unrelated Donor AlloHCT.
Salas MQ, Charry P, Pedraza A, Martínez-Cibrian N, Solano MT, Domènech A, Suárez-Lledó M, Nomdedeu M, Cid J, Lozano M, de-LLobet N, Arcarons J, Rosiñol L, Gutiérrez-García G, Carreras E, Esteve J, Urbano-Ispizua Á, Fernández-Avilés F, Rovira M, Martínez C. Salas MQ, et al. Among authors: de llobet n. Transplant Cell Ther. 2022 Aug;28(8):489.e1-489.e9. doi: 10.1016/j.jtct.2022.05.009. Epub 2022 May 14. Transplant Cell Ther. 2022. PMID: 35577323 Free article.
Effect of CD34+ Cell Dose on the Outcomes of Allogeneic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide.
Pedraza A, Salas MQ, Rodríguez-Lobato LG, Charry P, Suárez-Lledo M, Martínez-Cibrian N, Doménech A, Solano MT, Arcarons J, de Llobet N, Rosiñol L, Gutiérrez-García G, Avilés FF, Urbano-Ispízua Á, Rovira M, Martínez C. Pedraza A, et al. Among authors: de llobet n. Transplant Cell Ther. 2023 Mar;29(3):181.e1-181.e10. doi: 10.1016/j.jtct.2022.12.005. Epub 2022 Dec 14. Transplant Cell Ther. 2023. PMID: 36526259 Free article.
Post-Transplantation Cyclophosphamide and Tacrolimus for Graft-versus-Host Disease Prevention after Allogeneic Hematopoietic Cell Transplantation from HLA-Matched Donors Has More Advantages Than Limitations.
Salas MQ, Pedraza A, Charry P, Suárez-Lledó M, Rodríguez-Lobato LG, Brusosa M, Solano MT, Serrahima A, Nomdedeu M, Cid J, Lozano M, Arcarons J, de Llobet N, Rosiñol L, Esteve J, Urbano-Ispizua Á, Carreras E, Fernández-Avilés F, Rovira M, Martinez C. Salas MQ, et al. Among authors: de llobet n. Transplant Cell Ther. 2024 Feb;30(2):213.e1-213.e12. doi: 10.1016/j.jtct.2023.11.020. Epub 2023 Nov 30. Transplant Cell Ther. 2024. PMID: 38042256
Optimized GVHD Prevention in HLA-Mismatched Unrelated Allogeneic HCT Using a PTCY-Based Approach.
Pinto FR, Suárez-Lledó M, Guardia L, Charry P, Cid J, Lozano M, Pedraza A, de Llobet N, Corrius G, Moreno C, Esteve J, Serra C, Carreras E, Rosiñol L, Fernández-Avilés F, Rovira M, Martinez C, Salas MQ. Pinto FR, et al. Among authors: de llobet n. Eur J Haematol. 2024 Dec 30. doi: 10.1111/ejh.14378. Online ahead of print. Eur J Haematol. 2024. PMID: 39739412